4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-23-048029
Options or other derivatives
- Director acquired 6,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Meng Lei Director | 2023-09-11 | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | I | ||
Loading xslF345X05/ownership.xml…